Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Prostate Cancer and Prostatic Diseases|October 15, 2025
Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort studyRosalba Rosato, Stefano De Luca, Andrea Zitella, et al.
JAMA Network Open|October 17, 2023
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate CancerGiovannino Ciccone, Stefano De Luca, Marco Oderda, et al.
Urologia Internationalis|May 21, 2020
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in ItalyAngelo Porreca, Michele Colicchia, Daniele D'Agostino, et al.
World Journal of Urology|October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitorsUgo G Falagario, Anna Lantz, Ivan Jambor, et al.
BJU International|June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational studyBernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Prostate Cancer and Prostatic Diseases|October 15, 2025
Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort studyRosalba Rosato, Stefano De Luca, Andrea Zitella, et al.
JAMA Network Open|October 17, 2023
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate CancerGiovannino Ciccone, Stefano De Luca, Marco Oderda, et al.
Urologia Internationalis|May 21, 2020
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in ItalyAngelo Porreca, Michele Colicchia, Daniele D'Agostino, et al.
World Journal of Urology|October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitorsUgo G Falagario, Anna Lantz, Ivan Jambor, et al.
BJU International|June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational studyBernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.
Pageof 18